What Causes Menopause Hair Loss? A UK Guide

By the Mellenza team — last updated May 2026.

If you're reading this, the chances are you noticed it before anyone else did. The widening at the part. More hair on the brush. Fewer angles in front of the mirror that didn't make you wince. By the time most women in the UK end up searching what causes menopause hair loss, they have been living with the question for at least a year.

This guide is the answer most consultations don't give. We'll explain what's actually happening at the follicle, what the research literature has been saying since 2011, and why the conventional framing — "your follicles are dying, here's a wig referral" — is not what the science actually supports.

1. The hormonal mechanism — what's really going on

Menopause is, biologically, the decline of ovarian estrogen production. When estrogen drops, the balance between estrogen and androgens (testosterone and its derivatives) shifts. The total amount of testosterone often stays roughly the same — but the ratio of estrogen-to-androgen activity tilts toward androgens.

That ratio shift matters because of one specific molecule: DHT — dihydrotestosterone. DHT is produced from testosterone by an enzyme called 5-alpha-reductase, which is present at the hair follicle. In follicles that are genetically sensitive to it, DHT binds to androgen receptors at the follicle and shortens the anagen phase — the growth phase of the hair cycle.

Hair grows in cycles. Each follicle on your head is in one of three phases:

• Anagen — the active growth phase. In healthy scalp, this lasts 2–6 years.
• Catagen — a brief transition phase, around two weeks.
• Telogen — the resting phase, around three months. The follicle holds the completed hair before shedding it and starting a new cycle.

When DHT binds at a sensitive follicle, the anagen phase shortens. Over months and years, what was a four-year growth phase becomes eighteen months, then twelve, then six. Each new hair cycle produces a finer, shorter hair. Eventually the anagen phase becomes so brief that what's produced is barely a hair at all.

This is the visible pattern: thinning at the crown, widening at the part, more shedding. Not because each follicle is doing something dramatic. Because every follicle is doing slightly less, every cycle, until the cumulative effect becomes visible to you in the mirror.

2. Are the follicles actually dying?

This is the part that almost no GP consultation covers properly.

In 2011, a European dermatology research team published findings on the histology of androgenetic alopecia — the technical name for the most common pattern of hormonal hair loss, including the menopausal version. The follow-up research over the last fifteen years has consistently confirmed one core finding:

The follicle does not die. It is chemically silenced.

What this means in practice: when you look at the scalp under magnification in a woman with menopausal androgenetic alopecia, the follicle structure is largely intact. The stem cells are still there. The blood supply is still intact. The follicle is alive. It has been pushed into extended dormancy by sustained DHT activity, and the cycles it is running are too short to produce visible hair.

This is a meaningful distinction. A dead follicle cannot produce hair, no matter what you do. A silenced follicle can produce hair if the silencing is interrupted.

The framing that most women receive in consultation rooms — "androgenetic alopecia, you may need to consider toppers, here's a minoxidil prescription" — implies the first scenario. The dermatology research since 2011 supports the second.

3. Why the "your follicles are dying" framing persists

It's not that GPs are wrong. It's that the language menopausal women hear in ten-minute appointments is shaped by what fits into ten minutes.

"You may need to consider wigs or toppers" is short. "Your follicles are not dead, they are chemically silenced by sustained DHT exposure, and the silencing is at least partly reversible if you interrupt it locally" takes longer to explain — and it requires the clinician to take a position on what to do about it.

The treatments that do exist for menopausal androgenetic alopecia — minoxidil, finasteride (typically off-label in women), HRT — each have their own clinical considerations and don't always work in isolation. So the path of least resistance, time-wise, is to under-explain the mechanism and recommend the safest off-the-shelf option.

The unintended cost is that women who could benefit from understanding the mechanism — and from interventions that target it — leave the appointment thinking their follicles are dying. They aren't.

4. Telogen effluvium vs androgenetic alopecia — they're not the same thing

Two patterns of hair loss are common around menopause, and they get confused with each other.

Telogen effluvium is acute. Something — a major life event, a viral illness, a sudden hormonal shift, a medication change, a nutritional deficiency — pushes a large fraction of follicles into telogen at once. Three months later, those follicles all shed at the same time. The shedding feels alarming because it's volume, not pattern. There is no widening at the part, no thinning at the crown — there is just a lot more hair coming out everywhere.

Telogen effluvium usually resolves on its own once the trigger is removed. It is a separate clinical entity from menopausal androgenetic alopecia.

Menopausal androgenetic alopecia is chronic. It is the slow widening at the part, the slow thinning at the crown, the slow change in hair texture over months and years. It is driven by the DHT-mediated anagen shortening described above. It does not resolve on its own — the trigger (the post-menopausal hormonal milieu) is permanent, and the silencing accumulates.

Some women have both at once. A major stressor at age 51 can trigger a telogen effluvium episode against the backdrop of slowly progressing androgenetic alopecia. This is why "I'm losing handfuls of hair" and "my part is widening" can be true at the same time.

5. Genetic vulnerability — why some women, not others

Not every woman experiences menopausal hair thinning. The variability comes down to follicle-level androgen receptor sensitivity, which is largely inherited.

If your mother, your maternal grandmother, your paternal grandmother, or your father's female relatives experienced thinning in their fifties or sixties, the chances that your follicles are similarly androgen-receptor-sensitive are higher. This is not destiny — environmental factors and intervention timing matter — but the genetic loading is real.

The other side of this: if you have the genetic loading and are now experiencing the visible pattern, you've already passed the point where "wait and see" is the right strategy. The longer follicles spend in extended dormancy, the more committed the dormancy becomes. The window during which intervention is most effective is the window many women spend on watchful waiting.

6. What the research has been saying since 2011

The dermatology literature since 2011 has converged on three points:

1. The mechanism is local DHT activity at the follicle. Not "hair death." Not "scalp aging." DHT, locally produced and locally active.
2. Topical interventions can interrupt local DHT. Most prominently, topical caffeine has been studied for its association with reduced 5-alpha-reductase activity at the follicle and extension of the anagen phase. Other actives have similar published context.
3. Systemic interventions are blunt instruments for a local problem. Oral supplements pass through digestion and reach the follicle in trace amounts. Topical interventions deliver actives directly to the site of the silencing.

This is the research basis for why Mellenza is a topical scalp serum, not a supplement. The silencing is local. The intervention has to be local too.

7. What you can actually do

Here is the practical answer, structured by what each approach is and isn't.

Topical scalp serums (Mellenza category)

Applied directly to the scalp daily. Built around interrupting local DHT activity and supporting the follicle's microenvironment. Works on the mechanism described above — the anagen-shortening one. Best evidence base for women whose pattern fits androgenetic alopecia (widening at the part, thinning at the crown).

Minoxidil (topical, prescription or OTC)

Different mechanism — it's a vasodilator that widens the small blood vessels around the follicle. Some women respond well. Requires permanent use, and there is a "dread shed" in the first weeks. Stacks fine with topical scalp serums.

HRT

Replaces declining estrogen systemically. For some women it slows or partly reverses the hair changes; for others it doesn't move the needle on hair specifically (though it transforms other menopausal symptoms). HRT alone is rarely sufficient for established androgenetic alopecia.

Oral finasteride / spironolactone (off-label)

Systemic anti-androgen interventions. Effective for some women, but require clinical supervision and have side-effect profiles worth understanding before starting. Generally a clinical-grade decision, not an OTC one.

Nutrition + general health

Iron, ferritin, B12, vitamin D, thyroid. Worth checking. Correcting a deficiency is necessary if one exists. Correcting a non-existent deficiency does nothing — and most women in the UK with menopausal hair changes are not iron- or B12-deficient. The supplements market is built on selling solutions to problems most customers don't have.

8. When to see a clinician

See a GP or trichologist if any of the following are true:

• Hair loss is rapid and patchy (could indicate alopecia areata, an autoimmune condition that needs different treatment).
• You see scarring, redness, or scaling at the scalp (could indicate scarring alopecia, which is urgent — the follicle damage in scarring alopecia is permanent).
• You have other unexplained symptoms — fatigue, weight changes, irregular periods, mood — that might point to thyroid dysfunction or another systemic cause.
• You're already on a structured intervention and want to add something to it (HRT + topical serum + minoxidil, for example, is a reasonable stack to discuss with someone clinically qualified).

For most women experiencing the slow, pattern-based widening and thinning that is menopausal androgenetic alopecia — and who have ruled out the items in the bullet list above — the right next step is daily topical intervention, not another GP appointment.

9. The summary, in five sentences

1. Menopause hair loss is driven by a hormonal shift that increases DHT activity at sensitive follicles.
2. DHT shortens the anagen growth phase. Over time, hairs become finer and shorter, and the follicle appears to stop producing.
3. The follicle is not dead. It is chemically silenced. The stem cells, blood supply, and structure are intact.
4. Interrupting local DHT — most directly with a topical scalp serum — can extend anagen and bring the follicle back to producing visible hair.
5. The earlier the intervention, the better the response. The longer follicles spend in extended dormancy, the more committed the dormancy becomes.

If you've made it to the end of this article and the pattern matches what you've been seeing, the place to start is the 12-week topical protocol. Or the ingredients page if you want to read what the research says about each active before committing.

Frequently asked

Is menopausal hair loss permanent? Not in the sense most women fear. The follicles are not dead — they are chemically silenced. With sustained, mechanism-targeted intervention (most directly, topical interruption of local DHT), most women see visible regrowth within 9–12 weeks.

Can supplements regrow hair? Most over-the-counter supplements marketed for hair growth are addressing presumed deficiencies that most users don't have. They pass through digestion systemically; only a tiny fraction of any active ingredient reaches the follicle. The mechanism research since 2011 points to topical interventions as the more direct fit for menopausal androgenetic alopecia.

How long until I see results? Most women on a daily topical scalp serum protocol notice less shedding by week 4, texture changes by week 6, and visible new growth at the part by week 9–12. The protocol is twelve weeks because the hair cycle is twelve weeks.